K. Müllner

发表

Have Biologics Changed the Natural History of Crohn's Disease?

P. Lakatos, M. Mandel, P. Miheller, 2014, Digestive Diseases.

The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients

P. Miheller, I. Hritz, A. Szijártó, 2022, Viruses.

Update on the pharmacogenomics of proton pump inhibitors.

Z. Tulassay, L. Herszényi, K. Hagymási, 2011, Pharmacogenomics.

Low bone mass in microscopic colitis

Z. Tulassay, P. Lakatos, P. Miheller, 2011, BMC gastroenterology.

Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease – A nationwide Hungarian cohort study

K. Farkas, F. Nagy, T. Molnár, 2019, Expert opinion on biological therapy.

Intracerebroventricular injection of clonidine releases β-endorphin to induce mucosal protection in the rat

S. Fürst, K. Gyires, A. Rónai, 2000, Neuropharmacology.

Involvement of central KATP channels in the gastric antisecretory action of α2-adrenoceptor agonists and β-endorphin in rats

S. Fürst, K. Gyires, A. Rónai, 2002 .

SEMMELWEIS UNIVERSITY SCHOOL OF PH.D. STUDIES – PHARMACOLOGICAL SCIENCES Ph.D. thesis The role of the central nervous system in the regulation of gastric acid secretion and mucosal protection – involvement of central α2-adrenergic and opioid-receptors

K. Müllner, 2002 .

Involvement of the opioid system in the central antisecretory action of alpha-2 adrenoceptor agonists in rat

S. Fûrst, K. Gyires, K. Müllner, 2001, Journal of Physiology-Paris.

[Sedation and analgesia during gastrointestinal endoscopy].

Z. Tulassay, K. Müllner, 2011, Orvosi hetilap.

Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy

P. Igaz, Z. Tulassay, K. Rácz, 2007, Clinical endocrinology.

Activation of central opioid receptors may induce gastric mucosal defence in the rat

K. Gyires, A. Rónai, K. Müllner, 2001, Journal of Physiology-Paris.

Gyrus cinguli transection abolishes delta-opioid receptor-induced gastroprotection and alters alpha 2 adrenoceptor activity in the lower brainstem in rats

M. Palkovits, I. Barna, K. Gyires, 2002, Brain Research.

Neonatal monosodium glutamate treatment abolishes both delta opioid receptor-induced and alpha-2 adrenoceptor-mediated gastroprotection in the lower brainstem in rats

M. Palkovits, I. Barna, K. Gyires, 2001, Journal of Physiology-Paris.

Increased bone resorption and lower bone density in microscopic colitis

T. Zágoni, Z. Tulassay, M. Tóth, 2008 .

Alpha-2 adrenergic and opioid receptor-mediated gastroprotection

K. Gyires, A. Rónai, K. Müllner, 2000, Journal of Physiology-Paris.

Age and monosodium glutamate treatment cause changes in the stimulation-induced [3H]-norepinephrine release from rat nucleus tractus solitarii-dorsal vagal nucleus slices.

M. Palkovits, S. Fürst, M. Al-Khrasani, 2004, Life sciences.

Probiotics in the management of Crohn's disease and ulcerative colitis.

Z. Tulassay, P. Miheller, L. Herszényi, 2014, Current pharmaceutical design.

Update on the pharmacogenomics of proton pump inhibitors.

Z. Tulassay, L. Herszényi, K. Hagymási, 2011, Pharmacogenomics.

Functional evidence that gastroprotection can be induced by activation of central alpha(2B)-adrenoceptor subtypes in the rat.

K. Gyires, A. Rónai, K. Müllner, 2000, European Journal of Pharmacology.